Over the past decade, the Pharmaceuticals in Dosage Market Size Value Per Capita in Finland has shown notable fluctuations. Starting at $1.17K per capita in 2012, the value peaked at $1.21K in 2014, but then experienced a steady decline, hitting a low of $0.93908K in 2019. A slight recovery was observed in 2020 and 2021 with values of $1.02K and $1.08K respectively, before dropping again to $0.97268K in 2022.
For the past two years, the year-on-year variation shows a decline followed by a stabilization trend. The Compound Annual Growth Rate (CAGR) over the last five years indicates a moderate decrease in the market size. As of 2023, the value stood relatively stable compared to previous years.
Looking ahead to 2024, the trend suggests a cautious outlook with potential marginal growth or further stabilization. Key factors to watch include global economic conditions, regulatory changes, and advancements in pharmaceutical technologies which could influence market dynamics.
How does Finland rank in Pharmaceuticals in Dosage Market Size Value Per Capita?
| # | 59 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 1,580 | 2023 | View data | ||
| 2 | 2 Germany | 1,460 | 2023 | View data | ||
| 3 | 3 Denmark | 1,300 | 2023 | View data | ||
| 4 | 4 Iceland | 1,220 | 2023 | View data | ||
| 5 | 5 Norway | 1,070 | 2023 | View data | ||
| 11 | 11 Canada | 909.67 | 2023 | View data | ||
| 12 | 12 Sweden | 902.21 | 2023 | View data | ||
| 13 | 13 Finland | 892.66 | 2023 | |||
| 14 | 14 Australia | 887.11 | 2023 | View data | ||
| 15 | 15 Lithuania | 821.56 | 2023 | View data | ||
